BioAge Labs Inc (NASDAQ:BIOA)’s traded shares stood at 0.37 million during the last session. At the close of trading, the stock’s price was $5.50, to imply a decrease of -6.46% or -$0.38 in intraday trading. The BIOA share’s 52-week high remains $26.62, putting it -384.0% down since that peak but still an impressive 30.0% since price per share fell to its 52-week low of $3.85. The company has a valuation of $197.18M, with an average of 1.67 million shares in intraday trading volume over the past 10 days and average of 763.68K shares over the past 3 months.
BioAge Labs Inc (NASDAQ:BIOA) trade information
After registering a -6.46% downside in the last session, BioAge Labs Inc (BIOA) has traded red over the past five days. The 5-day price performance for the stock is 6.38%, and -72.08% over 30 days. With these gigs, the year-to-date price performance is -69.96%. Short interest in BioAge Labs Inc (NASDAQ:BIOA) saw shorts transact 2.37 million shares and set a 11.43 days time to cover.
The extremes give us $7 and $45 for target low and target high price respectively. As such, BIOA has been trading -718.18% off suggested target high and -27.27% from its likely low.
BIOA Dividends
BioAge Labs Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have AB Cap Fd.-AB Small Cap Growth Port and Principal Small Cap Growth Fd I as the top two Mutual Funds with the largest holdings of the BioAge Labs Inc (BIOA) shares. Going by data provided on Oct 31, 2024 , AB Cap Fd.-AB Small Cap Growth Port holds roughly 629.52 shares. This is just over 1.76% of the total shares, with a market valuation of $3.46 million. Data from the same date shows that the other fund manager holds a little less at 274.39, or 0.77% of the shares, all valued at about 1.51 million.
